About Kidemis
Kidemis is a company based in Basel (Switzerland) founded in 2022 by Constantin Marakhov, John Ericsson, and Sean Wassermann. Kidemis has raised $164.53 thousand across 1 funding round from investors including Venture Kick. Kidemis offers products and services including Mycoprotein Aquafeed and Sterile Substrate for Mycelium. Kidemis operates in a competitive market with competitors including Enifer, KnipBio, Salem Microbes, Techna Group and Algaennovation, among others.
- Headquarter Basel, Switzerland
- Founders Constantin Marakhov, John Ericsson, Sean Wassermann
-
Sectors
Agriculture
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$164.53 K (USD)
in 1 rounds
-
Latest Funding Round
$164.53 K (USD), Seed
Apr 12, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kidemis
Kidemis offers a comprehensive portfolio of products and services, including Mycoprotein Aquafeed and Sterile Substrate for Mycelium.
Protein alternative from sidestreams to replace fishmeal in aquaculture.
Base material for growing mycelium in sustainable feed production.
Funding Insights of Kidemis
Kidemis has successfully raised a total of $164.53K through 1 strategic funding round. The most recent funding activity was a Seed round of $164.53 thousand completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Kidemis
Kidemis has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Venture Kick.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
University backed startup accelerator
|
Locked | Locked | Locked |
Investor details for Kidemis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kidemis
Investment portfolio details for Kidemis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kidemis
Detailed financials for Kidemis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kidemis Comparisons
Peer comparison for Kidemis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kidemis
Kidemis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enifer, KnipBio, Salem Microbes, Techna Group and Algaennovation, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Fungi-based proteins are developed for sustainable food chain solutions.
|
|
| Locked | Locked | Locked |
All-natural feed ingredients are developed to enhance aquaculture productivity.
|
|
| Locked | Locked | Locked |
Develops microbial technologies for agriculture, environmental, and industrial applications.
|
|
| Locked | Locked | Locked |
Provider of precision animal nutrition and natural health solutions
|
|
| Locked | Locked | Locked |
Aquaculture farms are owned and operated in Israel.
|
Detailed competitors of Kidemis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kidemis
Complete news archive for Kidemis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kidemis
Kidemis was founded in 2022 and raised its 1st funding round 2 years after it was founded.
Kidemis is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Constantin Marakhov is the current CEO of Kidemis. They have also founded this company.
Kidemis is a funded company, having raised a total of $164.53K across 1 funding round to date.
Kidemis was founded in 2022 in Basel, Switzerland, within the sustainable biotechnology sector. Alternatives to traditional fishmeal and fish oil are produced for aquafeed applications through mycelium-based fermentation processes that yield mycoprotein. Operations center on creating environmentally viable feed solutions to support aquaculture growth, with a focus on reducing reliance on marine resources. The company is led by co-founders including Constantin Marakhov as CEO.
Kidemis's top competitors include Enifer, KnipBio and Techna Group.
Kidemis offers Mycoprotein Aquafeed and Sterile Substrate for Mycelium.
Kidemis has 1 investor. Key investors include Venture Kick.